T2687 |
Omeprazole sulfide
|
73590-85-9
|
98.77%
|
|
Omeprazole sulfide (Ufiprazole), a metabolite of Omeprazole, functions as a proton pump inhibitor.
|
T8386 |
Esomeprazole Magnesium trihydrate
|
217087-09-7
|
98.71%
|
|
Esomeprazole Magnesium trihydrate ((S)-Omeprazole magnesium trihydrate) is a proton pump inhibitor indicated for the short-term treatment of gastroesophageal ref...
|
T20714 |
Levolansoprazole
|
138530-95-7
|
98.62%
|
|
Levolansoprazole ((S)-Lansoprazole), a proton pump inhibitor, irreversibly inhibits H+/K+-stimulated ATPase pumps in parietal cells (IC50: 5.2 μM). It also inhib...
|
T10221 |
Abeprazan hydrochloride
|
1902954-87-3
|
98.62%
|
|
Abeprazan hydrochloride (Fexuprazan hydrochloride) is an effective reversible potassium-competitive acid blocker with oral activity, inhibiting H+, K+ -atPase by...
|
T6368 |
Abscisic Acid
|
21293-29-8
|
98.57%
|
|
Abscisic Acid (Dormin) is a plant hormone, which is involved in many plant developmental processes, modulates ion homeostasis and metabolism, and inhibits germin...
|
T5449 |
Bamaquimast
|
135779-82-7
|
98.40%
|
|
Bamaquimast (L 0042) is an inhibitor of proton pump
|
TQ0184 |
Chebulinic acid
|
18942-26-2
|
98.4%
|
|
Chebulinic acid is a potent inhibitor of M. tuberculosis DNA gyrase. It also can inhibit SMAD-3 phosphorylation and H+ K+-ATPase activity.
|
T21651 |
Lansoprazole sodium
|
226904-00-3
|
98.35%
|
|
Lansoprazole sodium (Lansoprazole (sodium)) is a proton pump inhibitor (PPI) and a potent inhibitor of gastric acidity which is widely used in the therapy of gas...
|
T0161 |
Pantoprazole Sodium Hydrate
|
164579-32-2
|
98.32%
|
|
Pantoprazole Sodium Hydrate (BY1023 (sodium hydrate)) is a proton pump inhibitor drug, used for short-term treatment of erosion and ulceration of the esophagus c...
|
T17030 |
Tegoprazan
|
942195-55-3
|
98.22%
|
|
Tegoprazan is a potassium-competitive acid blocker and is a potent, oral active, and highly selective inhibitor of gastric H+/K+-ATPase. That could control gastr...
|
T20626 |
Esomeprazole
|
119141-88-7
|
98.20%
|
|
Esomeprazole is the S-isomer of omeprazole, inhibits the lysosomal cysteine protease legumain to prevent cancer metastasis. Esomeprazole is a proton pump inhibit...
|
T40437L |
Caloxin 2A1 acetate
|
|
98.2%
|
|
Caloxin 2A1 acetate is an inhibitor of extracellular plasma membrane Ca2+-ATPase (PMCA) peptide. Caloxin 2A1 acetate inhibits Ca2+-dependent formation of the 140...
|
T0757 |
Omeprazole
|
73590-58-6
|
97.61%
|
|
Omeprazole (Losec) is a proton pump inhibitor (PPI), Omeprazole(Losec) is a potent brain penetrant neutral sphingomyelinase (N-SMase) inhibitor (exosome inhibito...
|
T16865 |
SCH28080
|
76081-98-6
|
97.12%
|
|
SCH28080 is a reversible and K+-competitive inhibitor of gastric H+/K+-ATPase with an IC50 value of 20 nM (rabbit microsomal membrane).SCH28080 is a potent inhib...
|
T11191 |
EN6
|
1808714-73-9
|
95.16%
|
|
EN6-mediated ATP6V1A modification decouples the v-ATPase from the Rags, leading to inhibition of mTORC1 signaling, increased lysosomal acidification and activati...
|
T8388 |
Vonoprazan
|
881681-00-1
|
100%
|
|
Vonoprazan (TAK-438 (free base)) is an orally active potassium-competitive acid blocker.Vonoprazan can be used for the treatment of gastroduodenal ulcer and refl...
|
TN1103 |
Diphyllin
|
22055-22-7
|
|
|
Diphyllin could be characterized as a new V-ATPase inhibitor in treating gastric cancer and inhibiting the phosphorylation of LRP6 in Wnt/β-catenin signaling.
|
T21254 |
Vonoprazan Fumarate
|
881681-01-2
|
|
|
Vonoprazan Fumarate (TAK438) , a novel potassium-competitive acid blocker, inhibits gastric acid secretion. Vonoprazan Fumarate (TAK438) inhibited H+,K+-ATPase a...
|
T16682 |
Pumaprazole
|
158364-59-1
|
98%
|
|
Pumaprazole (BY-841) is an antagonist of a reversible proton pump.
|
T6700 |
Tenatoprazole
|
113712-98-4
|
98%
|
|
Tenatoprazole (TU-199), a prodrug of the proton pump inhibitor (PPI) class, can inhibit proton transport (IC50: 3.2 μM).
|